Skip to main content
. 2012 Oct 31;94(3):753–763. doi: 10.1016/j.rvsc.2012.09.025

Table 5.

Total group and detailed individual clinical score values for each parameter evaluated in FeLV cats during rFeIFNω therapy.

Detailed individual clinical scores
Cat 8 Cat 9 Cat 10 Cat 11 Cat 12 Cat 13
Clinical parameter/Day 0 10 30 65 0 10 30 65 0 10 30 65 0 10 30 65 0 10 30 65 0 10 30 65
Oral ulcers 2 2 2 1 0 0 0 0 2 2 1 1 1 1 1 1 2 2 2 0 2 2 2 2
Caudal Stomatitis 0 0 0 0 0 0 0 0 2 2 2 1 0 0 0 0 0 0 0 0 0 0 0 0
Ophthalmological abnormalities 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 2 0 1 1 1 1 1
Lymphadenopathy 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
Ocular discharge 0 0 1 0 0 0 1 1 1 0 1 0 0 0 0 0 0 2 1 0 1 0 0 0
Nasal discharge 0 0 1 0 1 1 1 1 1 1 1 0 0 0 0 0 0 2 1 0 2 2 2 0
Mucous membranes 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0
Dry coat/seborrhea 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0 1 1 1 1
Body condition 0 0 1 1 1 0 0 0 0 0 2 1 0 0 0 0 0 2 2 1 1 0 0 0
Faecal Appearance 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0 0 0
Concurrent Diseases 0 0 0 0 1 1 1 1 0 0 1 1 1 1 1 0 0 0 0 0 2 2 2 2



Total (individual) 2 2 5 2 3 2 3 3 6 5 11 4 2 2 2 1 3 14 9 3 11 8 6 6



Total group clinical scores
Day 0 10 30 65
Total (sum) 27 33 36 19